Cellectra™ Human CD14 NanoSort Microbeads, Research grade

製品番号/仕様
価格
Availability
数量
MBS-S001-1X10^9cells
$513.00
MBS-S001
製品金額 :
$ 0
推奨新製品 Request Quote
Contact Us
Contact Us
製品金額:
$ 0
  • 製品詳細
  • データ表示
  • Reviews & Citations
  • Important Statement
  • Resources
  • Product
    Size
    Amount
    Cellectra™ Human CD14 NanoSort Microbeads, Research grade
    2 mL Reconstitution Buffer
    For 10⁹ total cells
  • Product Show

    CD14 PRODUCT SHOW

    This product is compatible with mainstream automated cell processing instruments and commercially available column-based (M/D/L) magnetic separation systems.

  • Product Description

    Cellectra™ Human CD14 NanoSort Microbeads are 50 nm dextran-coated superparamagnetic iron oxide nanoparticles which the surface is conjugated with recombinant monoclonal antibodies specific to human CD14 (Isotype: mouse IgG1). They are especially designed for positive selection of CD14+ cells.
    Cellectra™ Human CD14 NanoSort Microbeads are produced under sterile manufacturing conditions (ISO 5), and no animal- or human-derived components are used throughout the production process. It is produced under our rigorous quality control system that includes a comprehensive set of tests including sterility and endotoxin tests.

  • Application

    Cellectra™ Human CD14 NanoSort Microbeads are designed for the positive selection of monocytes and macrophages from fresh or frozen human peripheral blood mononuclear cells (PBMCs). CD14, a glycosylphosphatidylinositol (GPI)-anchored membrane protein, is predominantly expressed on the surface of human monocytes and macrophages. The magnetic nBeads are conjugated with monoclonal antibodies targeting human CD14 protein, enabling CD14+ cells to be labeled with the specific antibodies and magnetic particles, and separated using the separation columns and magnets.

  • Storage

    This product is stable after storage at: 2-8°C for 36 months in lyophilized state; 2-8°C for 18 months under sterile conditions after reconstitution.

    Please protect from light and avoid repeated freeze-thaw cycles. Immediate use after reconstitution is highly recommended.

  • Sterility

    Negative

  • Endotoxin

    Less than 0.002 EU per μL by the LAL method / rFC method.

  • Mycoplasma

    Negative

  • Important Note

    This product is for research use only and not intended for therapeutic or in vivo diagnostic use.

  • Formulation

    Lyophilized in PBS with 0.1% recombinant HSA, pH 7.4. Trehalose is added as protectant before lyophilization.

  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process